Moderna, Inc. vs OncoMed
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $44 M for OncoMed in the year to December 2018.
- Both made a net loss: $2.8 B for Moderna, Inc. and $8 M for OncoMed.
- OncoMed keeps more of each dollar of sales: a net margin of -18.2% against -145.2% for Moderna, Inc.
Market cap history
● Moderna, Inc.● OncoMed
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #275 in the world | OncoMed OMED |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | 2004 |
| Size | ||
| Market cap | $90.1 B | — |
| Revenue | $1.9 B | $44 M |
| Net income | $-2.8 B | $-8 M▲ best |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9% | — |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap — |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which makes more money, Moderna, Inc. or OncoMed?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $44 M for OncoMed in the year to December 2018. Both made a net loss: $2.8 B for Moderna, Inc. and $8 M for OncoMed.
Which is more profitable, Moderna, Inc. or OncoMed?
OncoMed keeps more of each dollar of sales: a net margin of -18.2% against -145.2% for Moderna, Inc.
More about Moderna, Inc.
More about OncoMed
Sources#
Every figure on this page comes from these, with the date shown next to it.